Bio-Techne (TECH) News
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
72.67-0.03 (-0.04%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TECH news summary
We found 33 recent headlines mentioning Bio-Techne (TECH): 0 in the past week and 9 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, TECH is down 0.04% at $72.67. The most recent story, "CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates", was published by Nasdaq on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Bio-Techne headlines
- CorMedix (CRMD) Reports Q3 Loss, Tops Revenue EstimatesCorMedix (CRMD) delivered earnings and revenue surprises of +55.56% and +3.89%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqCRMD, TECH
- Humacyte, Inc. (HUMA) Reports Q3 Loss, Tops Revenue EstimatesHumacyte, Inc. (HUMA) delivered earnings and revenue surprises of +22.22% and +19.54%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqHUMA, TECH
- TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal AdvancesBio-Techne's Q1 fiscal 2027 earnings and revenues beat estimates, driven by Protein Sciences growth, as its merger with Merck KGaA moves closer to completion.NasdaqTECH, ISRG, MEDP, GEHC
- Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Tops Revenue EstimatesMontes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +53.66% and +1,252.37%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies…NasdaqROIV, TECH
- Bio-Techne Q1 Profit Down(RTTNews) - Bio-Techne Corporation (TECH) reported that its first quarter net earnings declined to $28.29 million or $0.18 per share from $38.19 million or $0.24 per share last year.Nasdaq
- Bio-Techne Corporation Declares Quarterly Dividend of $0.08 Per ShareBio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarterly dividend will be…NasdaqTECH, WSO.B
- Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Beats Revenue EstimatesRhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of +10.29% and +9.07%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the…NasdaqRYTM, TECH
- CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Tops Revenue EstimatesCRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -8.49% and +27.39%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the…NasdaqCRSP, TECH
- Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?TECH's Q1 earnings are on deck, with revenues and EPS growth expected as investors weigh segment performance and the pending $11.3 billion acquisition.NasdaqTECH, ACHC, TGTX, RVTY
- Lennox International Moves Up In Market Cap Rank, Passing Bio-TechneIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Lennox International Inc (Symbol: LII) has taken over the #464 spot from Bio-Techne Corp…NasdaqLII, TECH, HEI.A
- S&P 500 sectors face strong historical tailwinds after mid-October closeSeeking Alpha
- INCY or TECH: Which Is the Better Value Stock Right Now?INCY vs. TECH: Which Stock Is the Better Value Option?NasdaqINCY, TECH
- Bio-Techne Shareholders Approve Merck KGaA Acquisition Plan(RTTNews) - Wednesday, Bio-Techne Corp. (TECH) announced that its shareholders have approved the acquisition of the company by Merck KGaA (MKKGY.PK), Darmstadt, Germany, marking an important…Nasdaq
- Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqTECH, MRNA
- Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.NasdaqBIO, DHR, TECH
- TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock RisesBio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.NasdaqLH, DGX, TECH, MEDP
- Techne (TECH) Q4 Earnings Meet EstimatesTechne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?Nasdaq
- Bio-Techne Posts Q4 Net Profit As Expenses Drop, Net Sales Improve(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments, and services, on Wednesday reported net profit for the fourth quarter of fiscal 2026.Nasdaq
- JAZZ vs. TECH: Which Stock Is the Better Value Option?JAZZ vs. TECH: Which Stock Is the Better Value Option?NasdaqJAZZ, TECH
- Can These 3 MedTech Stocks Hit Targets This Earnings Season?Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the MedTech trends and company-specific drivers in focus.NasdaqCRL, TECH, ZBH
- RSP, TECH, PYPL, CRL: ETF Inflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Equal Weight ETF (Symbol: RSP) where we have detected…NasdaqRSP, TECH, PYPL, CRL
- Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?TECH heads into fiscal fourth-quarter earnings with revenues expected to remain flat, EPS projected to decline, and its $11.3 billion acquisition deal in focus.NasdaqTECH, NBIX, WST, HNGE
- Noteworthy ETF Outflows: RSP, MRNA, TECH, GPCLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Equal Weight ETF (Symbol: RSP) where we have detected…NasdaqRSP, MRNA, TECH, GPC
- RSP, MRNA, TECH, GPC: Large Inflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Equal Weight ETF (Symbol: RSP) where we have detected…NasdaqRSP, MRNA, TECH, GPC
- Bio-Techne Takes Over #477 Spot From Charles River Laboratories InternationalIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Bio-Techne Corp (Symbol: TECH) has taken over the #477 spot from Charles River Laboratories…NasdaqTECH, CRL
- Bio-Techne Corporation (TECH) Merck KGaA - M&A Call - SlideshowSeeking Alpha
- Bio-Techne Corporation (TECH) M&A Call TranscriptSeeking Alpha
- Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)Seeking Alpha
- Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking AlphaTECH, BAC
- Bio-Techne Corporation (TECH) Q3 2026 Earnings Call TranscriptSeeking Alpha
- Bio-Techne Corporation (TECH) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha
- Bio-Techne Corporation (TECH) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha
- Bio-Techne Corporation (TECH) Q2 2026 Earnings Call TranscriptSeeking Alpha